Latest News and Press Releases
Want to stay updated on the latest news?
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 1 August 2014, Bruce Burlington, a Director of the Company notified us that, on 1 August 2014, he purchased...
-
Transaction by Persons Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 1 August 2014, Leif Johansson, a Director of the Company notified us that, on 1 August 2014, he sold and...
-
Sammanfattning: Intäkterna under andra kvartalet uppgick till 6 454 MUSD, en ökning med 4% i fasta valutakurser (CER), det andra kvartalet i rad med intäktstillväxt (Q2 2013: 6 232 MUSD). Vinst per...
-
AstraZeneca PLC SECOND Quarter AND HALF YEAR Results 2014 London, 31 July 2014 Click on, or paste the following link into your web browser, to view the associated PDF...
-
4 PIPELINE UPDATE - ASTRAZENECA DEVELOPMENT PIPELINE, 30 JUNE 2014 Click on, or paste the following link into your web browser, to view the associated PDF...
-
AstraZeneca Second Quarter & Half Year Results 2014 Tomorrow, Thursday, 31 July 2014, AstraZeneca will release second quarter and half year results for 2014 at 07:00 bst. An analyst presentation of...
-
ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 30 June 2014, Pascal Soriot, a Director of the Company, notified us that, on 30 June 2014, he purchased...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 26 June 2014, Marc Dunoyer, a Director of the Company, notified us that, on 25 June 2014, he purchased...
-
AstraZeneca today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 11 to 2 that current evidence from clinical studies does not support an...